共 89 条
[1]
Zhang W(2006)EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 65 1312-1324
[2]
Doherty M(2012)2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Arthritis Care Res 64 1447-1461
[3]
Bardin T(2020)2020 American College of Rheumatology guideline for the management of gout Arthritis Rheumatol 72 879-895
[4]
Pascual E(2006)Newer therapeutic approaches: gout Rheumatic Dis Clin N Am 32 235-244
[5]
Barskova V(2005)Febuxostat compared with allopurinol in patients with hyperuricemia and gout N Engl J Med 353 2450-2461
[6]
Conaghan P(2007)Assessment of outcome in clinical trials of gout—a review of current measures Rheumatology 46 1751-1756
[7]
Khanna D(2009)Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients J Rheumatol 36 1699-1704
[8]
Khanna PP(2007)Quality of care for gout in the US needs improvement Arthritis Rheum 57 822-829
[9]
Fitzgerald JD(2017)2016 updated EULAR evidence-based recommendations for the management of gout Ann Rheum Dis 76 29-42
[10]
Singh MK(2012)Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial Am J Med 125 1126-1134